Bristol Myers Squibb Co
Close on Nov 20, 2026Market cap $120.19BP/E 13.0Yield 4.23%
Bristol Myers Squibb GAAP Cost of Products Sold by Quarter
GAAP Cost of Products Sold ($M) ($M)
Bristol Myers Squibb GAAP Cost of Products Sold: $4,146M in Q3 2026, up 20.7% from a year earlier.
Where the Q3 2026 figure comes from
“|| Cost of products sold | $ | 4,146 | $ | (13) | $ | 4,133 | $ | 11,292 | $ | (41) | $ | 11,252”
Source: Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Bristol Myers Squibb GAAP Cost of Products Sold ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Bristol Myers Squibb SEC filings and investor materials. https://stockdatahq.com/stocks/bmy/kpis/gaap-cogs-rec
See every metric in the Bristol Myers Squibb KPI table. Data updated Nov 3, 2026.
See a number that looks wrong?